Please Note: This trial is no longer enrolling new participants
First-in-human, open-label, multicenter, Phase I/IIa, dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of BNT142 in patients with CLDN6-positive advanced solid tumors
Protocol No. | CTO-BNT142-01 | Scope | National |
---|---|---|---|
Principal Investigator | Jennifer King | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I/II |